Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment?

HIGHLIGHTS

• who: Hirokazu Nakayama from the Department of Pharmacy, NTT Medical Center Tokyo, u20119u2011, Higashiu2011Gotanda, Shinagawau2011Ku, Tokyo, u20118625, Japan have published the Article: Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment?, in the Journal: (JOURNAL) of March/16,/2009
• what: The aims of this study were to reveal whether increases in lymphocytes and/or reduction of NLR is associated with development of CKD in patients on longterm dasatinib treatment. Among them, 31 patients were excluded for the following reasonsu2012dasatinib treatment duration less than 6 months . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.